|
Vaccine Detail
CEA RNA-pulsed Autologous Human Cultured Dendritic Cells |
Vaccine Information |
- Vaccine Name: CEA RNA-pulsed Autologous Human Cultured Dendritic Cells
- Target Pathogen: Cancer
- Target Disease: Cancer
- Vaccine Ontology ID: VO_0007359
- Type: Recombinant vector vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Host Species as Laboratory Animal Model: Human
- CEACAM5 (CEA)
gene engineering:
- Type: Recombinant protein preparation
- Description:
- Detailed Gene Information: Click Here.
- Description: Autologous human dendritic cells pulsed with RNA encoding the carcinoembryonic antigen (CEA) are being studied for possible use in the treatment of cancer expressing CEA. (NCIT_C2710).
|
Host Response |
|
References |
NCIT_C2710: [https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C2710]
|
|